Keith Bell, University of British Columbia

Research

Bladder Cancer Bladder Preservation Comparative Effectiveness Implementation Science Neoadjuvant Chemotherapy Radiation Therapy Radical Cystectomy

Latest funding

Active surveillance vs definitive local therapy for patients showing clinical complete response following neoadjuvant cisplatin-based chemotherapy
CIHR · 2023 · Principal investigator
$200,000

All 1 grants and awards

Active surveillance vs definitive local therapy for patients showing clinical complete response following neoadjuvant cisplatin-based chemotherapy

Principal investigatorCIHR2023Catalyst Grant: SPOR Innovative Clinical Trials (iCT)

Principal investigators: St-Laurent, Marie-Pier; Bell, Keith; Black, Peter C; Eigl, Bernhard J; Noonan, Krista

Keywords: Bladder Cancer; Bladder Preservation; Comparative Effectiveness; Implementation Science; Neoadjuvant Chemotherapy; Radiation Therapy; Radical Cystectomy

$200,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Bladder Cancer Dear Professor Bell, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on bladder cancer connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Active surveillance vs definitive local therapy for patients showing clinical complete response following neoadjuvant cisplatin-based chemotherapy" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]